KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to $589.0 million.

  • Acadia Pharmaceuticals' Short-term Investments rose 4360.08% to $589.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $589.0 million, marking a year-over-year increase of 4360.08%. This contributed to the annual value of $436.4 million for FY2024, which is 7441.65% up from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Short-term Investments of $589.0 million as of Q3 2025, which was up 4360.08% from $508.4 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Short-term Investments registered a high of $589.0 million during Q3 2025, and its lowest value of $112.0 million during Q1 2023.
  • In the last 5 years, Acadia Pharmaceuticals' Short-term Investments had a median value of $296.5 million in 2022 and averaged $335.7 million.
  • As far as peak fluctuations go, Acadia Pharmaceuticals' Short-term Investments crashed by 5354.71% in 2023, and later soared by 13734.57% in 2024.
  • Acadia Pharmaceuticals' Short-term Investments (Quarter) stood at $373.3 million in 2021, then dropped by 19.1% to $302.0 million in 2022, then dropped by 17.14% to $250.2 million in 2023, then skyrocketed by 74.42% to $436.4 million in 2024, then soared by 34.97% to $589.0 million in 2025.
  • Its Short-term Investments was $589.0 million in Q3 2025, compared to $508.4 million in Q2 2025 and $463.9 million in Q1 2025.